Want to join the conversation?
$JNJ said that its estimated free cash flow for FY15 was at $15.9Bil, an increase of $1.1Bil compared to last year. In the company's Consumer segment, results outside the US were driven by strong sales of upper respiratory products and relaunch of anti-smoking products, while in the Pharmaceutical segment, sales outside the US fell approx. 0.2%.
$AAL is getting stronger into Dec. after a strong Nov..!! I’m feeling confident about their 4Q revenue forecast for a margin rise.
$KO’s CEO Muhtar Kent to step down next year. COO James Quincey will take the helm in what is already a smooth sailing scenario. And as always, shares reflect by growing 2% after the market opened.